Clinical Evaluation of 18F-AV-1451

Conditions

Mental Health & Behavioral Research

Phase II

What is the purpose of this trial?

Brief Summary:

This study is designed to expand the database of 18F-AV-1451 safety and tau binding as measured by PET imaging and to provide standardized conditions for 18F-AV-1451 use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury.


http://www.alzheimers.yale.edu



  • Trial with
    Avid Radiopharmaceuticals
  • Start Date
    10/19/2017
  • End Date
    07/30/2018

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Joanna Harris

  • Last Updated
    05/03/2018
  • Study HIC
    #2000021572